Navigation Links
Pharma Medical Science Liaison Outreach Shifting Away from Traditional Company Sales Regions
Date:8/22/2011

CHAPEL HILL, N.C., Aug. 22, 2011 /PRNewswire/ -- With the support of Key Opinion Leaders clearly linked to success in the marketplace, competition for the time and attention of KOLs is intensifying. But the changing regulatory and access environment has altered the landscape for creating and maintaining KOL and physician relationships.

To help biopharma organizations navigate this new KOL landscape, Best Practices, LLC has published an updated MSL-focused report that highlights the optimal size, mix and service frequencies of these elite medical specialists.

The 78-page report, "Medical Science Liaisons: Gaining Access and Forging Relationships with Key Opinion Leaders (Updated for 2011)," presents 2011 data compared to data gathered in 2009 on an array of critical questions that provide insights into how MSLs can build strong, productive relationships with KOLs and physicians.

One of the emerging trends in 2011 involves a change in how MSLs are deployed in the field.  According to the study:

  • Benchmarked companies appear to have shifted away from aligning MSLs to reflect a sales region or geographic distribution. Companies have moved towards deploying based on the concentration of KOLs in a given area; 79% of companies deploy along this model.

With interviews and key insights drawn from 27 leaders at 24 leading bio-pharmaceutical companies, this Best Practices, LLC benchmarking study identifies a wealth of strategies and proven tactics that helps Medical Affairs and other executives to effectively determine the optimal number of liaisons, mix of responsibilities, number of interactions and span of control that are critical to build strong and productive relationships over the life of a brand.

The full 78-page report contains more than 600 benchmark metrics and scores of executive narratives that companies can use to benchmark key management factors reflecting size, service levels and roles of Medical Science Liaisons in serving KOLs and hard-to-see physicians.

Key topics of this primary research include:

  • Benchmark pre and post-launch service activities
  • Identify drivers of group size & focus
  • Gain insight into structuring & aligning medical with sales organizations
  • Identify optimal call frequencies and service levels with thought leaders
  • Budget allocation to MSL function  

To learn more about the study, download a complimentary summary at http://www.best-in-class.com/rr1107.htm.

For more information, contact Cameron Tew, Executive Director of Research and Publishing at Best Practices, LLC at (919) 767-9246 or ctew@best-in-class.com.

BEST PRACTICES, LLC conducts work based on the simple yet profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies. Best Practices, LLC has been a leader in pharmaceutical research and consulting for more than 17 years; our clients include 48 of the top 50 pharmaceutical companies.


'/>"/>
SOURCE Best Practices, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Endo Pharmaceuticals Announces Leadership Change at HealthTronics Subsidiary: Appoints Kelly Huang, Ph.D. New President
2. CVS Caremark Appoints Mark S. Cosby as President of CVS/pharmacy
3. Specialty Pharma Association Announces Fall Conference
4. Enox Biopharma, Inc. Will Be Granted its Foundation Patent
5. Spaulding Clinical Announces Strategic Partnership with Clinigene International, India for Providing Comprehensive Early Clinical Solutions to Pharmaceutical and Biotech Clients
6. Food and Drug Administration (FDA) Joins Pharma IQs Viral Safety 2011 Conference
7. Valeant Pharmaceuticals Completes Acquisition of Sanitas Group
8. Pharmaceutics International, Inc. (Pii) Successfully Completes EMA and FDA Inspection
9. NY Top Drugstore Lobbyist Admits Mail-Service Pharmacy Saves Money... But Pushes Gov. Cuomo to Sign a Bill to Stop Employers From Using it
10. CoLucid Pharmaceuticals Receives Clearance for Investigational New Drug (IND) Application for Lasmiditan for the Treatment of Acute Migraine
11. Valeant Pharmaceuticals Announces Resignation of Michael Van Every From Valeants Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... 11, 2017  BioPharmX Corporation (NYSE MKT: BPMX) researchers ... an innovative way to use nonlinear optical imaging to ... new drugs. ... will show how researchers from BioPharmX and the Wellman ... used a suite of imaging techniques in what is ...
(Date:10/11/2017)... FRISCO, Texas , Oct. 11, 2017 /PRNewswire/ ... healthcare services, has amplified its effort during National ... patients about hereditary cancer risks. ... Journal of Clinical Oncology calculated that more than ... to have inherited mutations in BRCA1 or BRCA2 and ...
(Date:10/10/2017)... received FDA 510(k) clearance in May 2017 for its highly anticipated ... for endoscopy environments. An innovative secondary monitor solution, ZeroWire Mobile ... the improvement of patient outcomes, procedural efficiency, and the lowering of ... ... By ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... 13, 2017 , ... ProVest Insurance Group, a family managed ... Raleigh regions, is organizing an extended charity drive to benefit the family of ... , After struggling since birth with several health challenges, T.J. was later diagnosed ...
(Date:10/13/2017)... ... 13, 2017 , ... The International Association of Eating Disorders ... for the field of eating disorders, announces the opening of early registration for ... Florida at the Omni Resort at ChampionsGate. , The annual iaedp™ ...
(Date:10/13/2017)... SAN LUIS OBISPO, Calif. (PRWEB) , ... October 13, 2017 , ... ... with Alzheimer’s or dementia. However, many long-term care insurance companies have a waiver for ... mean is the 90-day elimination period, when the family pays for care, is often ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... ... will be giving viewers the lowdown on sciatica in a new episode of ... that focuses on current events and innovation and investigates each subject in-depth with ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... sleep apnea using cutting-edge Oventus O2Vent technology. As many as 18 ... characterized by frequent cessation in breathing. Oral appliances can offer significant relief to ...
Breaking Medicine News(10 mins):